Pharmanewsintel.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title News and Research on Pharma , Bio Tech, Clinical Trials and Clinical Research - PharmaNewsIntelligence
Description The Latest News and Research on Pharma , Bio Tech, Clinical Trials and Clinical Research
Keywords N/A
Server Information
WebSite pharmanewsintel favicon www.pharmanewsintel.com
Host IP 104.26.11.149
Location United States
Related Websites
Site Rank
rxdatascience.com #1,400,775
scienceboard.net #509,165
datakitchen.io #835,484
More to Explore
pidecomida.net
philhuntparts.com.au
pineapplie.wordpress.com
pilatesequipment.fitness
pipminds.com
plantasde.es
platamex.com
plancaribe.com
playmotiv.com
planeta.website
allassport.se
alltomservice.se
Pharmanewsintel.com Valuation
US$12,417
Last updated: Aug 22, 2020

Pharmanewsintel.com has global traffic rank of 1,377,454. Pharmanewsintel.com has an estimated worth of US$ 12,417, based on its estimated Ads revenue. Pharmanewsintel.com receives approximately 2,268 unique visitors each day. Its web server is located in United States, with IP address 104.26.11.149. According to SiteAdvisor, pharmanewsintel.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$12,417
Daily Ads Revenue US$6
Monthly Ads Revenue US$204
Yearly Ads Revenue US$2,483
Daily Unique Visitors 2,268
Note: All traffic and earnings values are estimates.
Traffic Ranks
Global Rank 1,377,454
Delta (90 Days) 0
Most Popular In Country N/A
Country Rank N/A
DNS Records
Host Type TTL Data
pharmanewsintel.com A 299 IP: 104.26.10.149
pharmanewsintel.com A 299 IP: 104.26.11.149
pharmanewsintel.com A 299 IP: 172.67.70.13
pharmanewsintel.com AAAA 299 IPv6: 2606:4700:20:0:0:0:681a:a95
pharmanewsintel.com AAAA 299 IPv6: 2606:4700:20:0:0:0:ac43:460d
pharmanewsintel.com AAAA 299 IPv6: 2606:4700:20:0:0:0:681a:b95
pharmanewsintel.com NS 21599 Target: sandy.ns.cloudflare.com.
pharmanewsintel.com NS 21599 Target: bart.ns.cloudflare.com.
pharmanewsintel.com TXT 299 TXT: ca3-5a560392c88d42bdbafc7a06a543b9f9
pharmanewsintel.com SOA 3599 MNAME: bart.ns.cloudflare.com.
RNAME: dns.cloudflare.com.
Serial: 2034518165
Refresh: 10000
Retry: 2400
Expire: 604800
Minimum TTL: 3600
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Sat, 22 Aug 2020 22:18:21 GMT
Content-Type: text/html; charset=iso-8859-1
Transfer-Encoding: chunked
Connection: keep-alive
Set-Cookie: __cfduid=d228d1d12d80fa1846fc5241fc113ff3c1598134701; expires=Mon, 21-Sep-20 22:18:21 GMT; path=/; domain=.pharmanewsintel.com; HttpOnly; SameSite=Lax
Location: https://pharmanewsintel.com/
CF-Cache-Status: DYNAMIC
cf-request-id: 04b9d9643400000ce17ca60200000001
Server: cloudflare
CF-RAY: 5c6ff819e8790ce1-EWR

HTTP/2 200 
date: Sat, 22 Aug 2020 22:18:22 GMT
content-type: text/html; charset=UTF-8
set-cookie: __cfduid=d994f5b651abe3929d038eb7ff15e108d1598134701; expires=Mon, 21-Sep-20 22:18:21 GMT; path=/; domain=.pharmanewsintel.com; HttpOnly; SameSite=Lax
set-cookie: exp_last_visit=1282774701; expires=Sun, 22-Aug-2021 22:18:21 GMT; Max-Age=31536000; path=/; domain=.pharmanewsintel.com; secure; HttpOnly
set-cookie: exp_last_activity=1598134701; expires=Sun, 22-Aug-2021 22:18:21 GMT; Max-Age=31536000; path=/; domain=.pharmanewsintel.com; secure; HttpOnly
set-cookie: exp_csrf_token=deleted; expires=Thu, 01-Jan-1970 00:00:01 GMT; Max-Age=0; path=/; domain=.pharmanewsintel.com; secure; HttpOnly
set-cookie: exp_csrf_token=8747b0a437c179792d9e5445e74167ff12884d16; expires=Sun, 23-Aug-2020 00:18:21 GMT; Max-Age=7200; path=/; domain=.pharmanewsintel.com; secure; HttpOnly
x-frame-options: SAMEORIGIN
expires: Mon, 26 Jul 1997 05:00:00 GMT
last-modified: Sat, 22 Aug 2020 22:18:22 GMT
pragma: no-cache
vary: Accept-Encoding
x-hostname: ece006-fs1.nexcess.net
cf-cache-status: DYNAMIC
cf-request-id: 04b9d9648a0000156fd01fc200000001
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server: cloudflare
cf-ray: 5c6ff81a7ac6156f-EWR

Pharmanewsintel.com Whois Information
Not Available